Cargando…

Analysis of prognostic model based on immunotherapy related genes in lung adenocarcinoma

Lung cancer is one of the most common malignant tumors, and ranks high in the list of mortality due to cancers. Lung adenocarcinoma (LUAD) is the most common subtype of lung cancer. Despite progress in the diagnosis and treatment of lung cancer, the prognosis of these patients remains dismal. Theref...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Peng, Wang, Wenmiao, Liu, Lei, Li, HouQiang, Sha, XinYu, Wang, Silin, Huang, Zhanghao, Zhou, Youlang, Shi, Jiahai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9772350/ https://www.ncbi.nlm.nih.gov/pubmed/36543847 http://dx.doi.org/10.1038/s41598-022-26427-0

Ejemplares similares

Identification of a polycomb group-related gene signature for predicting prognosis and immunotherapy efficacy in lung adenocarcinoma
por: Liu, Lei, et al.
Publicado: (2023)

Identification of lysosomal genes associated with prognosis in lung adenocarcinoma
por: Li, Houqiang, et al.
Publicado: (2023)

Histone acetylation modification regulator-mediated tumor microenvironment infiltration characteristics and prognostic model of lung adenocarcinoma patients
por: Wang, Wenmiao, et al.
Publicado: (2022)

Exploration of the shared genes and signaling pathways between lung adenocarcinoma and idiopathic pulmonary fibrosis
por: Li, Houqiang, et al.
Publicado: (2023)

PRKCB is relevant to prognosis of lung adenocarcinoma through methylation and immune infiltration
por: Wang, Jinjie, et al.
Publicado: (2022)

Characteristic of molecular subtypes in lung adenocarcinoma based on m6A RNA methylation modification and immune microenvironment
por: Zhou, Hao, et al.
Publicado: (2021)

A cuproptosis-related lncRNAs risk model to predict prognosis and guide immunotherapy for lung adenocarcinoma
por: Li, Qixuan, et al.
Publicado: (2023)

Sustainably released nanoparticle-based rhynchophylline limits pulmonary fibrosis by inhibiting the TEK-PI3K/AKT signaling pathway
por: Wang, Shuo, et al.
Publicado: (2023)

Prognostic signature of lung adenocarcinoma based on stem cell-related genes
por: Huang, Zhanghao, et al.
Publicado: (2021)

Low expression of IL6R predicts poor prognosis for lung adenocarcinoma
por: Sun, Gaofeng, et al.
Publicado: (2021)

Loss of IL-34 Expression Indicates Poor Prognosis in Patients With Lung Adenocarcinoma
por: Wang, Zhendong, et al.
Publicado: (2021)

Identification of potential biomarkers associated with CD4(+) T cell infiltration in myocardial ischemia-reperfusion injury using bioinformation analysis
por: Wang, Wenmiao, et al.
Publicado: (2023)

Platelet-Membrane-Encapsulated Carvedilol with Improved Targeting Ability for Relieving Myocardial Ischemia–Reperfusion Injury
por: Zhou, Tingting, et al.
Publicado: (2022)

Characteristic of Molecular Subtypes in Lung Squamous Cell Carcinoma Based on Autophagy-Related Genes and Tumor Microenvironment Infiltration
por: Wang, Jinjie, et al.
Publicado: (2022)

Extrachromosomal circular DNA: a new potential role in cancer progression
por: Wang, Tianyi, et al.
Publicado: (2021)

Prognostic necroptosis-related gene signature aids immunotherapy in lung adenocarcinoma
por: Song, Yuqi, et al.
Publicado: (2022)

Characteristics of circadian rhythm-related genes and establishment of a prognostic scoring system for lung adenocarcinoma with experimental verification: a bioinformatics analysis
por: Zhang, Fengbin, et al.
Publicado: (2022)

Comprehensive Analysis of Ferroptosis Regulators in Lung Adenocarcinomas Identifies Prognostic and Immunotherapy-Related Biomarkers
por: Sun, Sijin, et al.
Publicado: (2021)

Prognostic model and immunotherapy prediction based on molecular chaperone-related lncRNAs in lung adenocarcinoma
por: Xu, Yue, et al.
Publicado: (2022)

Identification of Prognostic Risk Model Based on DNA Methylation-Driven Genes in Esophageal Adenocarcinoma
por: Chen, Yuhua, et al.
Publicado: (2021)

Exploration of an Prognostic Signature Related to Endoplasmic Reticulum Stress in Colorectal Adenocarcinoma and Their Response Targeting Immunotherapy
por: Xu, Yu, et al.
Publicado: (2023)

A Novel Immune-Related Prognostic Model for Response to Immunotherapy and Survival in Patients With Lung Adenocarcinoma
por: Zheng, Yujia, et al.
Publicado: (2021)

A Metabolism-Related Gene Prognostic Index for Prediction of Response to Immunotherapy in Lung Adenocarcinoma
por: Tang, Bo, et al.
Publicado: (2022)

A bioinformatics-based immune-related prognostic index for lung adenocarcinoma that predicts patient response to immunotherapy and common treatments
por: Wang, Chenghao, et al.
Publicado: (2022)

Prognostic value of immune related genes in lung adenocarcinoma
por: Wang, Han, et al.
Publicado: (2020)

Immunogenic cell death-based prognostic model for predicting the response to immunotherapy and common therapy in lung adenocarcinoma
por: Zhou, Xiang, et al.
Publicado: (2023)

Identification of a potential bioinformatics-based biomarker in keloids and its correlation with immune infiltration
por: Li, Zihan, et al.
Publicado: (2023)

Application of an angiogenesis-related genes risk model in lung adenocarcinoma prognosis and immunotherapy
por: Wang, Jinsong, et al.
Publicado: (2023)

A disulfidptosis-related lncRNA prognostic model to predict survival and response to immunotherapy in lung adenocarcinoma
por: Zhang, Hai-Bo, et al.
Publicado: (2023)

Age and treatment disparities in survival of primary malignant cardiac tumors: an analysis of over 40 years and 500 patients
por: Wang, Wenmiao, et al.
Publicado: (2023)

Development and validation of an immune‐related prognostic signature in lung adenocarcinoma
por: Sun, Sijin, et al.
Publicado: (2020)

Characteristics of hypoxic tumor microenvironment in non-small cell lung cancer, involving molecular patterns and prognostic signature
por: Huang, Zhanghao, et al.
Publicado: (2021)

Identification and validation of tumor microenvironment-related signature for predicting prognosis and immunotherapy response in patients with lung adenocarcinoma
por: Li, Chunhong, et al.
Publicado: (2023)

Prognostic value of ferroptosis‐related genes in patients with lung adenocarcinoma
por: Zhu, Guangsheng, et al.
Publicado: (2021)

Single-cell analysis reveals exosome-associated biomarkers for prognostic prediction and immunotherapy in lung adenocarcinoma
por: Lin, Shengrong, et al.
Publicado: (2023)

Integrative analysis of TP53 mutations in lung adenocarcinoma for immunotherapies and prognosis
por: Li, He, et al.
Publicado: (2023)

Computational immune profiling in lung adenocarcinoma reveals reproducible prognostic associations with implications for immunotherapy
por: Varn, Frederick S., et al.
Publicado: (2018)

A novel prognostic model related to oxidative stress for treatment prediction in lung adenocarcinoma
por: Peng, Haijun, et al.
Publicado: (2023)

Prognostic value of cancer-associated fibroblasts-related genes in lung adenocarcinoma
por: Li, Wenchao, et al.
Publicado: (2023)

A Pyroptosis-Related Signature Predicts Overall Survival and Immunotherapy Responses in Lung Adenocarcinoma
por: Zhu, Kaibin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_c3fe417gkp6bcadp7itrdjod7n